Literature DB >> 11288872

Towards a better understanding of the cisplatin mode of action.

V Marchán1, V Moreno, E Pedroso, A Grandas.   

Abstract

We have studied how platinum(II) complexes [Pt(dien)Cl]Cl, [Pt(en)Cl2] and cisplatin react with hybrid molecules that contain sulfur and nitrogen ligands, in particular Phac-Met-linker-p5'dG (Phac = phenylacetyl), Phac-His-linker-p5'dG, Phac-His-Met-linker-p5'dG and Phac-His-Gly-Met-linker-p5'dCATGGCT. The progress of the reactions was monitored by HPLC, and by [1H,15N]-HSQC NMR when 15N-cisplatin was used. The products were isolated and characterised by using enzymatic and chemical reactions and spectroscopic techniques (UV and/or NMR spectroscopy, electrospray or MALDI-TOF mass spectrometry). The combined use of digestion with proteases and reaction with hydrogen peroxide followed by mass spectrometric analysis indicated the platinum coordination positions on the peptide moiety of the largest hybrid. Monofunctional Pt-S adducts were transformed into Pt-N complexes in which Pt-N7 bonds were formed preferentially. Most of the chelates isolated had Pt-S bonds, and, in the case of cisplatin complexes, loss of the ammine trans to sulfur gave rise to the formation of tricoordinate species with platinum-mediated peptide-nucleotide cross-links. 1,2-Intrachain platinum GpG adducts were only obtained in very small amounts (1-4%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11288872     DOI: 10.1002/1521-3765(20010216)7:4<808::aid-chem808>3.0.co;2-6

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

Review 2.  Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?

Authors:  F Gieseler; P Rudolph; G Kloeppel; U R Foelsch
Journal:  Int J Colorectal Dis       Date:  2003-05-28       Impact factor: 2.571

3.  Incorporation of two modified nucleosides allows selective platination of an oligonucleotide making it suitable for duplex cross-linking.

Authors:  Berta Algueró; Enrique Pedroso; Vicente Marchán; Anna Grandas
Journal:  J Biol Inorg Chem       Date:  2007-05-30       Impact factor: 3.358

4.  Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro.

Authors:  Ahmad Zaim Mat Pauzi; Swee Keong Yeap; Nadiah Abu; Kian Lam Lim; Abdul Rahman Omar; Suraini Abdul Aziz; Adam Leow Thean Chow; Tamilselvan Subramani; Soon Guan Tan; Noorjahan Banu Alitheen
Journal:  Chin Med       Date:  2016-11-15       Impact factor: 5.455

5.  On the Heterogeneous Nature of Cisplatin-1-Methyluracil Complexes: Coexistence of Different Aggregation Modes and Partial Loss of NH3 Ligands as Likely Explanation.

Authors:  Sonja Pullen; Alexander Hegmans; Wolf G Hiller; André Platzek; Eva Freisinger; Bernhard Lippert
Journal:  ChemistryOpen       Date:  2021-01       Impact factor: 2.630

6.  The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry.

Authors:  Adrien Nyakas; Michael Eymann; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2008-12-31       Impact factor: 3.262

7.  Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy.

Authors:  Luis Alberto Esteves Batista de Carvalho; Adriana Pereira Mamede; Ana Lucia Marques Batista de Carvalho; Joana Marques; Gianfelice Cinque; Svemir Rudić; Maria Paula Matos Marques
Journal:  Biophys J       Date:  2021-06-30       Impact factor: 3.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.